Guggenheim Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.2M | Sell |
|
|||||
|
2025
Q1 | $51.2M | Sell |
|
|||||
|
2024
Q4 | $45.5M | Sell |
|
|||||
|
2024
Q3 | $55M | Sell |
|
|||||
|
2024
Q2 | $51M | Sell |
|
|||||
|
2024
Q1 | $57.3M | Buy |
|
|||||
|
2023
Q4 | $46.3M | Sell |
|
|||||
|
2023
Q3 | $52.5M | Sell |
|
|||||
|
2023
Q2 | $57.2M | Sell |
|
|||||
|
2023
Q1 | $74M | Sell |
|
|||||
|
2022
Q4 | $91.7M | Sell |
|
|||||
|
2022
Q3 | $86.7M | Sell |
|
|||||
|
2022
Q2 | $106M | Sell |
|
|||||
|
2022
Q1 | $132M | Buy |
|
|||||
|
2021
Q4 | $108M | Buy |
|
|||||
|
2021
Q3 | $80.4M | Buy |
|
|||||
|
2021
Q2 | $82.4M | Buy |
|
|||||
|
2021
Q1 | $78.5M | Sell |
|
|||||
|
2020
Q4 | $78.7M | Sell |
|
|||||
|
2020
Q3 | $64.4M | Sell |
|
|||||
|
2020
Q2 | $78.2M | Buy |
|
|||||
|
2020
Q1 | $52.9M | Sell |
|
|||||
|
2019
Q4 | $65.1M | Buy |
|
|||||
|
2019
Q3 | $48.7M | Sell |
|
|||||
|
2019
Q2 | $47.7M | Sell |
|
|||||
|
2019
Q1 | $54.9M | Buy |
|
|||||
|
2018
Q4 | $54.7M | Sell |
|
|||||
|
2018
Q3 | $67.9M | Sell |
|
|||||
|
2018
Q2 | $72.1M | Sell |
|
|||||
|
2018
Q1 | $141M | Sell |
|
|||||
|
2017
Q4 | $168M | Buy |
|
|||||
|
2017
Q3 | $146M | Sell |
|
|||||
|
2017
Q2 | $131M | Buy |
|
|||||
|
2017
Q1 | $116M | Sell |
|
|||||
|
2016
Q4 | $125M | Buy |
|
|||||
|
2016
Q3 | $121M | Buy |
|
|||||
|
2016
Q2 | $118M | Buy |
|
|||||
|
2016
Q1 | $102M | Buy |
|
|||||
|
2015
Q4 | $91.7M | Sell |
|
|||||
|
2015
Q3 | $85.6M | Sell |
|
|||||
|
2015
Q2 | $128M | Buy |
|
|||||
|
2015
Q1 | $100M | Buy |
|
|||||
|
2014
Q4 | $94.8M | Sell |
|
|||||
|
2014
Q3 | $92.4M | Buy |
|
|||||
|
2014
Q2 | $77.3M | Sell |
|
|||||
|
2014
Q1 | $114M | Buy |
|
|||||
|
2013
Q4 | $78.9M | Buy |
|
|||||
|
2013
Q3 | $62M | Buy |
|
|||||
|
2013
Q2 | $41.9M | Buy |
|